368 related articles for article (PubMed ID: 28882528)
1. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
[TBL] [Abstract][Full Text] [Related]
2. Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency.
Preisler N; Laforêt P; Echaniz-Laguna A; Ørngreen MC; Lonsdorfer-Wolf E; Doutreleau S; Geny B; Stojkovic T; Piraud M; Petit FM; Vissing J
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1235-40. PubMed ID: 23780368
[TBL] [Abstract][Full Text] [Related]
3. Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Preisler N; Orngreen MC; Echaniz-Laguna A; Laforet P; Lonsdorfer-Wolf E; Doutreleau S; Geny B; Akman HO; Dimauro S; Vissing J
Neurology; 2012 Jan; 78(4):265-8. PubMed ID: 22238410
[TBL] [Abstract][Full Text] [Related]
4. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
[TBL] [Abstract][Full Text] [Related]
5. Fat metabolism during exercise in patients with McArdle disease.
Ørngreen MC; Jeppesen TD; Andersen ST; Taivassalo T; Hauerslev S; Preisler N; Haller RG; van Hall G; Vissing J
Neurology; 2009 Feb; 72(8):718-24. PubMed ID: 19237700
[TBL] [Abstract][Full Text] [Related]
6. No spontaneous second wind in muscle phosphofructokinase deficiency.
Haller RG; Vissing J
Neurology; 2004 Jan; 62(1):82-6. PubMed ID: 14718702
[TBL] [Abstract][Full Text] [Related]
7. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
Lewis SF; Haller RG
J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113
[TBL] [Abstract][Full Text] [Related]
9. Fat and carbohydrate metabolism during exercise in late-onset Pompe disease.
Preisler N; Laforet P; Madsen KL; Hansen RS; Lukacs Z; Ørngreen MC; Lacour A; Vissing J
Mol Genet Metab; 2012 Nov; 107(3):462-8. PubMed ID: 22981821
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Haller RG; Vissing J
Arch Neurol; 2002 Sep; 59(9):1395-402. PubMed ID: 12223025
[TBL] [Abstract][Full Text] [Related]
11. Effect of changes in fat availability on exercise capacity in McArdle disease.
Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.
Delaney NF; Sharma R; Tadvalkar L; Clish CB; Haller RG; Mootha VK
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8402-8407. PubMed ID: 28716914
[TBL] [Abstract][Full Text] [Related]
13. Dose-response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease.
Valenzuela PL; Santalla A; Alejo LB; Merlo A; Bustos A; Castellote-Bellés L; Ferrer-Costa R; Maffiuletti NA; Barranco-Gil D; Pinós T; Lucia A
J Sport Health Sci; 2024 May; 13(3):398-408. PubMed ID: 38030066
[TBL] [Abstract][Full Text] [Related]
14. Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Ørngreen MC
Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399985
[TBL] [Abstract][Full Text] [Related]
15. Muscle glycogen unavailability and fat oxidation rate during exercise: Insights from McArdle disease.
Rodriguez-Lopez C; Santalla A; Valenzuela PL; Real-Martínez A; Villarreal-Salazar M; Rodriguez-Gomez I; Pinós T; Ara I; Lucia A
J Physiol; 2023 Feb; 601(3):551-566. PubMed ID: 36370371
[TBL] [Abstract][Full Text] [Related]
16. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle metabolic response to exercise in horses with 'tying-up' due to polysaccharide storage myopathy.
Valberg SJ; Macleay JM; Billstrom JA; Hower-Moritz MA; Mickelson JR
Equine Vet J; 1999 Jan; 31(1):43-7. PubMed ID: 9952328
[TBL] [Abstract][Full Text] [Related]
18. Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Vissing J; Quistorff B; Haller RG
Arch Neurol; 2005 Sep; 62(9):1440-3. PubMed ID: 16157752
[TBL] [Abstract][Full Text] [Related]
19. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
20. McArdle disease: a unique study model in sports medicine.
Santalla A; Nogales-Gadea G; Ørtenblad N; Brull A; de Luna N; Pinós T; Lucia A
Sports Med; 2014 Nov; 44(11):1531-44. PubMed ID: 25028051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
